Abstract
Although implantation of biomaterials carrying mesenchymal stem cells (MSCs) is considered as a promising strategy for ameliorating neural function after spinal cord injury (SCI), there are still some challenges including poor cell survival rate, tumorigenicity and ethics concerns. The performance of the secretome derived from MSCs was more stable, and its clinical transformation was more operable. Cytokine antibody array demonstrated that the secretome of MSCs contained 79 proteins among the 174 proteins analyzed. Three-dimensional (3D) printed collagen/silk fibroin scaffolds carrying MSCs secretome improved hindlimb locomotor function according to the Basso–Beattie–Bresnahan scores, the inclined-grid climbing test and electrophysiological analysis. Parallel with locomotor function recovery, 3D printed collagen/silk fibroin scaffolds carrying MSCs secretome could further facilitate nerve fiber regeneration, enhance remyelination and accelerate the establishment of synaptic connections at the injury site compared to 3D printed collagen/silk fibroin scaffolds alone group according to magnetic resonance imaging, diffusion tensor imaging, hematoxylin and eosin staining, Bielschowsky’s silver staining, immunofluorescence staining and transmission electron microscopy. These results indicated the implantation of 3D printed collagen/silk fibroin scaffolds carrying MSCs secretome might be a potential treatment for SCI.
Keywords: spinal cord injury, secretome, mesenchymal stem cells, 3D printing, collagen, silk fibroin
Introduction
Spinal cord injury (SCI) usually results in loss of motor, sensory and autonomic functions [1–6]. Non-permissive microenvironment inhibits central nervous system (CNS) axon regeneration after injury [7–10]. Glial and neuronal cell death, axon loss, demyelination, inflammation, glial scar formation, necrotic cavity, neurotrophic factor deficiency and other pathological changes occur after SCI, resulting in hostile microenvironment leading to permanent functional dysfunction, neurological deficits and limited regenerative capacity [11–14]. Despite extensive research, there is still no effective and definitive clinical treatment for SCI, especially, complete SCI [13]. Recent studies show that neurotrophic factor-based tissue engineering technology holds promise as a strategy for treating SCI [3, 10, 15–19]. With the insight from the combination of three-dimensional (3D) printing technology and tissue engineering technology, tissue engineering technology has created a new era of tissue repair [11, 20–22].
Cell transplantation can be used for the treatment of CNS diseases including SCI. Many studies have shown that mesenchymal stem cells (MSCs) can promote functional recovery in multifarious CNS models [23]. Increasing evidence indicates that MSCs can also ameliorate neurogenesis [24–26]. MSCs transplantation in clinical is limited by immunologic rejection, tumorigenicity and ethical concerns [17]. Many studies have indicated that paracrine factors are conducive to the therapeutic effects of MSCs [27–31]. Increasing evidence has demonstrated that secretome (ST) played a critical role in the MSCs-induced neural regeneration [28, 32–35].
The ST of MSCs contains many proteins composed of growth factors and cytokines, as well as vesicle parts of exosomes and microvesicles [36, 37]. The nature of the essential components of the therapeutic MSCs ST remains subtle. Sart et al. [38] indicated that the ST of MSCs could facilitate the endogenous secretion of the extracellular matrix of neural progenitor aggregates, as well as secreting transforming growth factor-β1 (TGF-β1), brain-derived neurotrophic factor and fibroblast growth factor-2 to accelerate cell adhesion and proliferation of the cells. Three-dimensional printed biomaterial not only controlled the release rate of ST in vivo, but also supported the adhesion, survival, migration and differentiation of neural stem cells (NSCs) [39, 40].
A wide variety of biomaterials are widely used to facilitate SCI repair. By bridging the two ends of the SCI area, biomaterials can reconnect the nerve tissue in the injured area, hinder scar formation, reduce inflammatory processes, rebuild nerve conduction circuits and prevent spinal neuron apoptosis, and ultimately ameliorate locomotion function after SCI [41, 42]. The basic parameters of biomaterials, such as biocompatibility, biodegradability, permeability and porosity, are critical in the study of neural tissue engineering [43]. Many natural and synthetic polymers are used as scaffold materials. Collagen, as a natural extracellular matrix component, is widely used in various tissue engineering studies because of its excellent biocompatibility, biodegradability, low immunogenicity and cell adhesion [11, 22, 44]. Some limitation, such as poor mechanical properties, weak manipulability and rapid degradation of collagen hinder its clinical application [45]. Silk fibroin possesses mechanical strength, significant elasticity and environmental stability. Silk fibroin is currently used as a biomaterial for soft tissue engineering and reconstruction [46, 47]. The addition of silk fibroin in collagen can make up for the shortcomings of using a collagen scaffold alone.
Good mechanical properties of biomaterials should guide axon regeneration before being completely biodegraded, and be strong enough to withstand stress from the spine and surrounding muscles [48]. The rapid biodegradation rate and low mechanical strength of certain natural materials have hindered their use as tissue engineering materials, and 3D printing technology is required to ameliorate their mechanical properties and bridge the two ends of the SCI area and obtain the favorable effect for SCI treatment. Furthermore, the application of tissue engineering is limited by the preparation technology. In SCI animal experiments, the diameter of the scaffold implanted at the injury site is only about 3 mm [49]. Traditional manufacturing technologies, such as particle leaching technology, extrusion technology and thermal compression, are actually difficult to achieve in the large-scale manufacturing of scaffolds with accurate internal microstructures. As a solid free-form manufacturing technology in tissue engineering, the latest advent of 3D printing provides a novel and feasible method to ameliorate the properties of scaffolds [49, 50]. During the 3D printing process, the print head prepares a 3D composite scaffold containing a series of 2D layers. Printing parameters can be continuously adjusted and optimized on the computer workstation [51, 52]. Three-dimensional printing technology integrates mechanical engineering, computer-aided design (CAD), reverse engineering technology, layered manufacturing technology and numerical control technology, so that it has high accuracy and can achieve a multi-level structure with the coexistence of large holes and micro holes. Therefore, this technology can print scaffolds with complex internal structures, control the size of pores and ensure the biological activity of biomaterials.
In the present study, we try to fabricate 3D printed collagen/silk fibroin scaffolds adsorbed with the ST of human umbilical mesenchymal stem cells (HUCMSCs) and aimed to investigate the repair effect of the implanted scaffold as well as their potential to reconstruct neural networks after SCI.
Materials and methods
Isolation, culture and analysis of HUCMSCs
According to existing methods [53, 54], HUCMSCs were isolated from the Wharton’s jelly of the umbilical cord provided by the Obstetrics and Gynecology Department of Characteristic Medical Center of People’s Armed Police Forces, and the pregnant woman and her family members signed the informed consent. After cutting the umbilical cord Wharton’s glue, it was treated with collagenase and 0.25% trypsin. The cell suspension was then obtained by filtering the digested mixture through a 100-μm filter. The extracted cells were cultured in an incubator with a volume fraction of 5% CO2 at 37°C, and the culture medium was changed once after 3 days. After 70–80% cell fusion, the cells were digested with 0.25% trypsin and subcultured. An inverted phase-contrast microscope was used to observe the morphology of HUCMSCs. The immunophenotype of HUCMSCs (p3-generation) was analyzed using immunofluorescence staining [55]. Rabbit polyclonal antibody against CD90 (1:200, Bioss, Beijing, China) and mouse polyclonal antibody against CD105 (1:200, Bioss, Beijing, China) were used as primary antibodies. The secondary primary antibodies were used: Alexa Fluor 568-conjugated (1:1000, Invitrogen, Carlsbad, CA, USA) and Oregon Green 488-conjugated secondary antibodies (1:1000, Invitrogen, Carlsbad, CA, USA). The images were observed and captured by using a fluorescence microscope (Leica TCS SP5, Germany). According to the existing method [53, 54], the flow cytometer was performed to analyze the surface antigen of HUCMSC (passage 3). The antibodies used were as follows: CD90, CD105, CD73, CD116, CD19, CD45 and HLA-DR antibodies (Abcam, Cambridge, UK). Cytomics FC500 flow cytometer (BD Biosciences, San Jose, CA) was used to analyze the positive rate of these antigens.
Isolation and collection of HUCMSCs–ST
The ST derived from HUCMSCs was obtained according to existing methods [56]. To generate the ST, primary HUCMSCs were seeded onto DMEM culture flasks (2 × 106 cells/flask (75 cm2) containing 10% fetal bovine serum and cultured for 24 h. The medium was then replaced with serum-free, low-glucose DMEM. The conditioned media was collected after 24 h of culture in serum-free low-glucose DMEM, and then centrifuged at 500 × g for 10 min once, followed by centrifugation at 800 × g for 15 min twice at 4°C. The supernatants were concentrated by ultrafiltration using a Minimate Tangential Flow Filtration (TFF) capsule system (PALL Corporation, Ann Arbor, MI) with a 100 kDa membrane. Subsequently, ST produced by 1 × 107 cells was concentrated to 20 μL. A bicinchoninic acid (BCA) protein assay kit (Beyotime, China) was performed to measure the proteins concentration of ST.
Cytokine antibody array
An antibody-based cytokine array system (RayBio Human Cytokine Antibody Array C Series 2000, RayBiotech Inc. Norcross, GA) was implemented to analyze a panel of specified proteins in supernatant of HUCMSCs as previously described [56]. In brief, after dilution with blocking buffer (at a ratio of 1:50 (v/v)), the samples were put in a pre-blocked array overnight at 4°C. After subsequent incubation in streptavidin-conjugated peroxidase for 2 h, membranes were exposed to a peroxidase substrate for 5 min, followed by developing on X-ray film. A Kodak ImageStation 4000 M (Eastman Kodak, Rochester, NY) was performed to analyze optical density (OD) with the background subtracted from the edge of the spots. A positive control spot on each array was obtained by normalizing the spot data.
Fabrication of scaffolds
Silk fibroin was fabricated with silkworm silk (Jiaxing, Zhejiang, China) following the previously reported method [57–59]. Silkworm silk was placed in 0.5% anhydrous sodium carbonate solution (Solarbio Science & Technology Co., Ltd. China) and treated at 98–100°C for 30 min (the operation was repeated three times, the first two times were using tap water, and the third time using ionized water to degumming), and then oven dried at 60°C. The ternary solution of CaCl2.CH3CH2OH.H2O (substance concentration ratio of 1:2:8, the amount of each substance used is 188.7 g, 197.54 ml, 244.8 ml) (Solarbio Science & Technology Co., Ltd. China) was prepared at 60°C to dissolve 50 g silk, and then a mixed solution was obtained in 2 h. The mixed solution was cooled, centrifuged in an 8000 r/min centrifuge for 10 min, and the supernatant was taken and placed in a 3500D dialysis bag. Dialysis was performed with flowing tap water for 48 h, deionized water for 1 day, and water was changed once every 2 h. After dialysis, the solution was placed in 40% PEG (molecular weight 20 000 polyethylene glycol, deionized water), concentrated for 7–8 h and concentrated to about 15% in order to obtain an appropriate concentration of silk fibroin solution. Collagen was fabricated by using the fresh bovine tendon according to the previous protocols [58–60]. The fresh bovine tendon was peeled off the outer membrane, crushed and soaked in 0.05 Mtris buffer (Solarbio Science & Technology Co., Ltd. China) for 24 h to obtain the precipitate. An acetic acid solution (North China Pharmaceutical Factory, China) containing pepsin (Solarbio Science & Technology Co., Ltd. China) was then added and the supernatant was collected. The supernatant was added to a 3.5 mol/l NaCL solution, and the salted-out precipitate was collected and dialyzed at 4°C for 5 days to get the collagen gel.
To fabricate scaffolds, the silk fibroin protein and collagen were evenly mixed at a mass ratio of 1:2 for later preparation of 3D printing. For low temperature 3D printing technology, 3D bioprinter (Regenovo Biotechnology Co., Ltd., Hangzhou, China) was implemented to create constructs at –20°C. CAD was used to construct a multi-hole support template. Modeling software (Solidworks Software, Dassault Systèmes, Vélizy, France) was performed to design the 3D printing model for this study, followed by converting the pre-designed STL 3D model into G code. The printing parameters of this study were as follows: nozzle diameter = 160 μm, extrusion speed = 0.17 mm/min, printing speed = 12 mm/s, thickness = 0.3 mm per layer, platform temperature = –20°C. After the collagen/silk fibroin mixed solution was put into the printer cartridge, the material was squeezed out from the printing nozzle under the control of the computer and quickly cooled into a solid form. After printing, the 3D solid molding was placed at –80°C overnight and vacuum freeze-dried for 48–72 h to form 3D collagen/silk fibroin scaffold (3D-C/S) with a stable morphology. Cylinder-shaped 3D-C/S scaffolds (2 mm ×3 mm ×3 mm) were manufactured with a hole punch and sterilized by 60Co (Jinpengyuan Irradiation Technology Co., Ltd., Tianjin, China). ST solution was sterilized by using a 0.22 μm filter (Millipore) at 4°C. Then to equilibrium binding, 0.1 g 3D printed collagen/silk fibroin scaffolds were soaked with 20 μL ST solution (200 μg) for 24 h at 4°C under sterile conditions to prepare 3D printed collagen/silk fibroin scaffolds adsorbed with ST derived from HUCMSCs (3D-C/S+ST). D-Hank’s solution was used to wash all scaffolds 30 min before use.
Determination of scaffold characteristics
As previously stated, ultrastructural observations of scaffolds were performed by using a scanning electron microscope (SEM) (Hitachi, Tokyo, Japan) [22]. The water absorption ratio and the porosity ratio were examined as previously described [22]. The dynamic mechanical properties of the scaffolds are used to represent the mechanical behavior of the support under cyclic load in wet state. The mechanical properties of the scaffolds were measured by Instron 5865 (Instron, Norwood, MA, USA) material testing machine. The scaffold was immersed in PBS (PH = 7.4) at 37°C for 24 h until equilibrium, and the elastic modulus of the compression strain of the three groups of samples was measured. A 0.5 Hz sawtooth waveform was used, the preload was 0.1 N, the increment was 50%, the speed was 100%/min and the cycle was repeated three times. Ten scaffolds were measured in each group of samples, and the mean value and standard deviation (SD) of the obtained data were calculated to obtain the elastic modulus parameters of the scaffolds. An infrared spectrometer (Nicolet 870; Thermo Fisher Scientific, Waltham, MA, USA) was used to analyze Fourier transform infrared spectroscopy of 3D-C/S, 3D-C/S+ST and ST [60]. Differential scanning calorimetry (DSC) (DSC822e differential scanning calorimeter; Mettler Toledo, Greifensee, Switzerland) was carried out to analyze the phase transition temperatures of 3D-C/S, 3D-C/S+ST and ST [60]. The X-ray diffractometer (D8 Advance, Germany) was used to perform crystallization analysis of 3D-C/S, 3D-C/S+ST and ST. The relevant parameters for X-ray diffractometry were as follows: tube voltage = 40 kV, tube current = 30 mA, target material was CuKα (= 0.15406 nm), scanning speed = 5°/min, step width = 0.02° and the diffraction angle range = 5°–90°.
Seeding of NSCs
NSCs isolated from embryonic Day 14 brains were cultured in the 3D-C/S and 3D-C/S+ST to evaluate the cytocompatibility of scaffolds according to the method previously reported [60, 61]. NSCs (passage 4) were seeded on 3D-C/S and 3D-C/S+ST at a density of 1 × 106/ml. An inverted phase contrast phase-contrast microscope (Nikon, Tokyo, Japan) was performed to observe the length of cell protrusions and angle of cell protrusions of NSCs on 3D-C/S and 3D-C/S+ST at 7 days after co-culture. The morphology and growth of the cells on 3D-C/S and 3D-C/S+ST were observed on Day 7 by using the SEM (Hitachi, Tokyo, Japan). Hematoxylin and eosin (HE) staining was implemented to assess the growth status of NSCs on 3D-C/S and 3D-C/S+ST on Day 7; 3D-C/S and 3D-C/S+ST were put into 96-well plates separately to quantify the cell adhesion rate. Twenty microliters of NSCs were seeded at a density of 5 × 106/ml per scaffold. Cell adhesion rate of NSCs was measured after incubation for 1, 12, 24, 36, 48, 60 and 72 h. The formula for calculating the cell adhesion rate was as follows: cell adhesion rate = (number of adherent cells/number of seeding cells) × 100%.
In vitro NSCs viability
To evaluate the effect of the scaffold on the proliferation of neural stem cells, the viability of neural stem cells is analyzed by Cell Counting Kit-8 (CCK-8) assay (Solarbio Science & Technology Co., Ltd); 100 μL of NSC was seeded on the 3D-C/S and 3D-C/S+ST in each well of the 96-well plate at a density of 1 × 109/L (five duplicate wells per group). At 1, 3, 5 and 7 days after co-culture, 10 μL CCK-8 solution was added to each well, followed by culture for 3 h. A multi-mode microplate reader (BioTek, Synergy2, USA) was implemented to detect the OD value at 450 nm.
Surgery for spinal cord transection and scaffold implantation
All rats’ experiments conformed to the ‘Policies for the Use of Animals and Humans in Neuroscience Research’ and were approved by the Institutional Animal Care and Use Committee of Logistics University of People’s Armed Police (PAP) (approval No. 2019-1183.6). The experimental procedures for all rats were approved by the Animal Ethics Committee for PAP Research with reference number 36793/68 for ethical approval.
According to the method previously reported [60], a complete transection of the 2 mm spinal cord segment at the T10 spinal cord level was performed on adult female Sprague-Dawley rats (250–280 g) to establish the rat SCI model. Immediately after exact hemostasis, 3D-C/S and 3D-C/S+ST were implanted to fill up the transected gap in the scaffold groups. According to different treatments method, all rats were randomized into four groups: (i) Sham group, (only laminectomy without SCI, n = 20); (ii) SCI group, (SCI without any implantation, n = 20); (iii) 3D-C/S group, (3D printed collagen/silk fibroin scaffolds were implanted into the transected gap in the rats with spinal cord transection, n = 20); (iv) 3D-C/S+ST group, (3D printed collagen/silk fibroin scaffolds adsorbed ST derived from HUCMSCs were implanted into the transected gap in the rats with spinal cord transection, n = 20). For postoperative care, the rats received penicillin for infection prevention within 7 days after surgery and manual bladder compression twice daily until reflex bladder control was restored.
Evaluation of locomotor function
The behavioral assessment on all rats in an open area was carried out by two observers blind to the experimental conditions to evaluate the degree of functional restoration after SCI according to the Basso–Beattie–Bresnahan (BBB) scale at 1 day before the operation, and at 1 day, 1, 2, 3, 4, 6 and 8 weeks after SCI (n = 10 for each group). All rats were subjected to an inclined-grid climbing test at 1 day before the operation, and at 1 day, 1, 2, 4, 6 and 8 weeks after SCI (n = 10 for each group). Rats could maintain the maximum angle of the board and the ground when the body was held for 5 s in two different positions on the board, and the angle to be measured was obtained. The bilateral hind limb movements of all rats were observed at 8 weeks after SCI.
Electrophysiological analysis
Neurophysiology monitoring setup was used to evaluate motor evoked potentials (MEP) with evoked potential equipment (Nicolet VikingQuest; Natus Medical Inc., Pleasanton, CA, USA) at 2, 4, 6 and 8 weeks after surgery (n = 10 for each group). Changes in the MEP latency and amplitude were observed. MEP was recorded to assess the functional status of motor axonal conduction. The implementation of electrophysiological analysis was based on previously established methods [11, 22]. Briefly, the cortical motor area at the intersection of the coronal and sagittal sutures was selected as the location of the stimulating electrode. The posterior tibial nerve was positioned to record the electrode. The parameters to be set were as follows: the stimulus intensity (46 V), the stimulation frequency (1 Hz) and the pulse width (0.2 ms). The MEP waveform can be obtained from the monitor and the amplitude and latency can be analyzed after electrical stimulation.
Magnetic resonance imaging and diffusion tensor imaging
To observe the morphology of the SCI area, magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) were carried out as previously described at 8 weeks after surgery (n = 10 for each group) [60]. To evaluate the continuity of the nerve fiber bundles in the spinal cord, diffusion tensor tractography (DTT), the number of regenerated nerve fibers at the injury site and fractional anisotropy (FA) values were obtained, which cannot be examined by MRI [3, 62]. Thirteen FA values were measured at 1.5-mm intervals between the rostral and caudal of each rat by using Trackvis software, followed by drawing FA value distribution map.
Histological analysis
At 8 weeks after SCI, HE staining and Bielschowsky’s silver staining were performed for pathological examination according to an established method (n = 10 for each group) [11, 63–65]. Ten slices were selected from every fifth section of the posterior ventral surface of the spinal cord. After taking photos, Image-Pro Plus software was performed for quantitative statistics. For HE staining, the SCI area (width 2 mm, length 3 mm) was selected to calculate the cavity area. For Bielschowsky’s silver staining, the SCI area (width 2 mm, length 3 mm) was selected to calculate Bielschowsky’s silver staining area.
Immunofluorescence staining
At 8 weeks after SCI, the rats were transcardially perfused with isotonic saline and then 4% paraformaldehyde. The spinal cord sections were embedded, followed by cryosection longitudinally into 20 μm slices. The primary antibodies were incubated with the samples of the injury/graft site overnight at 4°C (n = 10 for each group). The primary antibodies used were as follows: Neurofilament (NF), 1:200; Myelin Basic Protein (MBP), 1:500; PSD95, 1:500; SYP, 1:200 (Abcam, Cambridge, UK). The secondary antibodies (Alexa Fluor 568-conjugated (1:1000, Invitrogen, Carlsbad, CA, USA) and Oregon Green 488-conjugated (1:1000, Invitrogen, Carlsbad, CA, USA)) were applied to the samples and incubated at 37°C for 1 h. A fluorescent microscope (Leica TCS SP5, Germany) was carried out to observe the samples and capture the images. Two areas (0.40 mm × 0.40 mm) at the injury/graft site were selected separately. Image-Pro Plus software (Media Cybernetics) was performed for the quantitative analysis according to an established method [60].
Transmission electron microscopy
A Philips CM10 electron microscope (Eindhoven, Holland) was used to examine remyelination in the SCI area at Week 8 according to existing methods (n = 5 for each group) [66]. The sections at the injury/graft site were cut into ultrathin sections (100 nm thickness) by an ultramicrotome (Reichert E, Co, Vienna, Austria). The number of myelinated axons at the injury site was quantified by selecting at least 10 random fields per sample at ×1500 magnification. The myelinated axons diameter and thickness of myelin sheath at the injury site were measured by using Image-Pro Plus software (Media Cybernetics).
Statistical analysis
IBM SPSS Statistics 22 was used for statistical analyses. The quantitative data were represented as mean ± SD values. Two sets of data were compared by using an independent-samples t-test or two-way analysis of variance. When the P values < 0.05, a statistically significant difference was considered.
Results
Morphology and characteristic protein identification of HUCMSCs
The fusiform HUCMSCs at p3-generation were observed by using a phase-contrast microscope (Fig. 1A). The expression of surface markers CD90 and CD105 in HUCMSCs was detected by a fluorescent microscope (Fig. 1B–D). The results of flow cytometry showed that the expression rates of CD90, CD105 and CD73 were all > 95%, which also proved that HUCMSCs had been successfully extracted and the purity of HUCMSCs could meet the requirements of this experiment (Fig. 1E–H).
The proteins of HUCMSCs–ST
The concentration of ST, measured by a BCA protein assay kit, was measured to be ∼ 10 mg/ml. To ascertain therapeutic molecular mediators in the HUCMSCs ST, high-density protein arrays were used to analyze the levels of 174 key signaling proteins in ST. The results of the cytokine antibody array indicated that ST contained 79 proteins among the 174 proteins analyzed. The 79 proteins of ST were presented in detail in previously published studies [56].
Characterization of 3D-C/S+ST
3D-C/S+ST were prepared using a 3D bioprinter (Fig. 2A); 3D scaffolds were shown to be porous by light microscope (Fig. 2B), fluorescent microscope (Fig. 2C and D), SEM (Fig. 2E–G) and HE staining (Fig. 2H), facilitating cell adhesion and growth. Compared to C/S, the porosity ratio of 3D-C/S (P < 0.05) and 3D-C/S+ST (P < 0.05) was significantly increased, which promoted the diffusion of nutrient solution and tissue formation (Fig. 2I). The water absorption ratio of 3D-C/S (P < 0.01) and 3D-C/S+ST (P < 0.01) was lower compared to C/S, which facilitated the maintenance of ST (Fig. 2J). 3D-C/S (P < 0.05) and 3D-C/S+ST (P < 0.05) exhibited a significant increase in the elastic modulus compared to C/S, which provided support for tissue regeneration (Fig. 2K). 3D-C/S and 3D-C/S+ST showed similar porosity ratio, water absorption ratio and elastic modulus. Infrared spectrum showed that ST was successfully added to 3D printed collagen/silk fibroin scaffolds (Fig. 2L). Through the combination of ST, the absorption peak at 3281.62 cm−1 in 3D-C/S+ST distinctly increased compared to that in 3D-C/S alone (Fig. 2L). Moreover, compared with 3D-C/S, the absorption peak at 1536.09 cm−1 and 1637.53 cm−1 in 3D-C/S+ST were sharper and turned to a lower wave number (Fig. 2L). The results of the infrared spectroscopy indicated that hydrogen bonds between collagen/silk fibroin and ST may be formed. For DSC, Tm was the apex of the endothermic change caused by temperature, which might be caused by the denaturation of ST. The Tm value of 3D-C/S+ST (Fig. 2M) was higher than that of pure ST, which suggested that the interaction between ST and 3D printed collagen/silk fibroin might augmented the stability of ST. X-ray diffraction analysis suggested a sharp diffraction peak at 24.54° was observed and the crystallinity of the sample changed with the amount of silk fibroin added to collagen (Fig. 2N). In this experiment, 3D-C/S and 3D-C/S+ST showed favorable crystallinity, which was beneficial to the formation of the stability of the scaffold and the control of the degradation rate.
3D-C/S+ST showed favorable cytocompatibility
Immunofluorescence staining showed that Nestin was expressed in the neurospheres (Fig. 3A). After 7 days of co-culture, NSCs grew on the surface and in the pores of 3D-C/S+ST and 3D-C/S using phase-contrast microscope, SEM, HE staining and immunofluorescence staining (Fig. 3B–E). Simultaneously, the number of NSCs adhering to 3D-C/S+ST was significantly higher than that of 3D-C/S (Fig. 3B–E). The implantation of 3D-C/S+ST increased cell adhesion rate of NSCs compared to 3D-C/S at the same time point (Fig. 3F). Compared with implanting 3D-C/S, implanting 3D-C/S+ST showed a significant increase in the absorbance of NSCs based on CCK-8 assay (P < 0.05) (Fig. 3G). These results indicated that both 3D-C/S+ST and 3D-C/S scaffolds had cytocompatibility and 3D-C/S+ST group was more conducive to cell growth compared to 3D-C/S group. 3D-C/S+ST and 3D-C/S exhibited good cytocompatibility and therefore have the potential to be implanted in vivo for biomedical study.
HUCMSCs–ST released from the implant of 3D-C/S+ST facilitated locomotor function and electrophysiological activity after SCI
Three to eight weeks after surgery, BBB scores of the left and right hindlimbs in the 3D-C/S+ST group were significantly higher than those of the SCI group and 3D-C/S group (P < 0.05) (Fig. 4A and B). Eight weeks after surgery, the 3D-C/S+ST group showed a significantly increased BBB scores compared with SCI group (P < 0.01) and the 3D-C/S group (P < 0.05) (Fig. 4C and D). Consistent with the BBB scoring experiment, the results of the inclined-grid climbing experiment indicated that the slope angle was increased in the 3D-C/S+ST group compared to SCI group and the 3D-C/S group (Fig. 4E). Furthermore, implanting 3D-C/S+ST exhibited a significant increase in the slope angle compared to implanting 3D-C/S (P < 0.05) or without implanting scaffolds (P < 0.01) at 8 weeks after surgery (P < 0.05) (Fig. 4F). Compared with SCI group and 3D-C/S group, the hindlimb walking ability of 3D-C/S+ST group showed significantly better recovery (Fig. 4G).
Two, 4, 6 and 8 weeks after surgery, the amplitude and the latency of MEP showed improvement in the SCI group, the 3D-C/S group and the 3D-C/S+ST group (Fig. 5A–C). Eight weeks after surgery, 3D-C/S+ST group (amplitude: 0.85 ± 0.06 mV; latency: 5.41 ± 0.65 ms) enhanced the amplitude and reduced the latency compared to the SCI group (amplitude: 0.36 ± 0.06 mV, P < 0.01; latency: 8.03 ± 0.96 ms, P < 0.01) and the 3D-C/S group (amplitude: 0.64 ± 0.06 mV, P < 0.01; latency: 6.87 ± 0.69 ms, P < 0.05) (Fig. 5A–C). The amplitude and latency at 2, 4 and 6 weeks post-surgery showed statistical differences similar to those at 8 weeks post-surgery (Fig. 5A–C).
MRI and DTI indicated implanting 3D-C/S+ST enhanced nerve fibers tracts regeneration after SCI
Eight weeks after surgery, rats received the implantation of 3D-C/S+ST exhibited more connections at the injury area by T2 weighted imaging (T2WI )and more regenerative nerve fiber tract at the injury area, when compared with those received 3D-C/S and those that did not received any scaffolds (Fig. 6A). After implantation of 3D-C/S+ST for 8 weeks, the number of regenerated nerve fibers (83 ± 13.166) at the injury area was markedly more than that in the SCI group (23.26 ± 3.017, P < 0.01) and the 3D-C/S group (52.37 ± 7.158, P < 0.01) (Fig. 6B). These results indicated that implantation of 3D-C/S+ST might contribute to the regeneration of nerve fibers tracts in the host spinal cord.
There were prominently larger FA values at these locations (9 mm, 7.5 mm, 6 mm, 4.5 mm, 3 mm, 1.5 mm, –3 mm, –4.5 mm, –6 mm, –7.5 mm and –9 mm from the epicenter of the injury site) in the in the 3D-C/S group than in the SCI group and the 3D-C/S group (P < 0.05) (Fig. 6C). Consistent with the results of the MRI and DTT images, the 3D-C/S+ST group exhibits better repair than the SCI group and the 3D-C/S group at these locations (9 mm, 7.5 mm, 6 mm, 4.5 mm, 3 mm, 1.5 mm, –3 mm, –4.5 mm, –6 mm, –7.5 mm and –9 mm from the epicenter of the injury site) based on the FA value.
The implantation of 3D-C/S+ST markedly reduced cavity formation, facilitate nerve fiber regeneration and remyelination at the injury site
The improvement of locomotor function may be related to the histology of the SCI site. Histological analysis of the injured spinal cord was performed at 8 weeks postoperatively. Macroscopic observation indicated that the damaged area of 3D-C/S+ST group exhibited better connection and integration with host tissue than the SCI group and the 3D-C/S group (Fig. 7A). The average cavity area were markedly reduced in the 3D-C/S+ST group (2.458 ± 0.429 mm2) compared with the SCI group (4.202 ± 0.406 mm2) (P < 0.01) and the 3D-C/S group (3.059 ± 0.356 mm2) (P < 0.05) (Fig. 7B and C), which suggested implanting 3D-C/S+ST provided tissue support that integrated well with both ends of the SCI area. Implanting 3D-C/S+ST (2.26 ± 0.22 mm2) exhibited a significant increase in the Bielschowsky’s silver staining area at the injury site compared to implanting 3D-C/S (1.96 ± 0.23 mm2) (P < 0.05) or without implanting scaffolds (1.38 ± 0.24 mm2) (P < 0.01) at 8 weeks after surgery (Fig. 7E), suggesting that implanting 3D-C/S+ST could facilitate nerve fiber regeneration at the injury site. The implantation of 3D-C/S+ST markedly increased the number of NF-positive nerve fibers wrapped by MBP-positive myelin sheath structures at the injury site compared to the implantation of 3D-C/S or without any implantation (Fig. 8A), which indicated that implanting 3D-C/S+ST could facilitate nerve fiber regeneration and remyelination at the injury site. At 8 weeks after surgery, rats that received the implantation of 3D-C/S+ST significantly exhibited more myelinated axons, bigger diameter of myelinated axons and thicker myelin sheath at the injury site by transmission electron microscopy (TEM), when compared with those received 3D-C/S and those that did not received any scaffolds (Fig. 8B–E), which suggesting that implanting 3D-C/S+ST could facilitate remyelination at the injury site.
The implantation of 3D-C/S+ST could increase the formation of synaptic connections at the injury site
Double-labeled immunofluorescence staining of PSD95 and SYP at the injury/graft site were performed to assess whether implanting 3D-C/S+ST increase the formation of synaptic connections at the injury site at 8 weeks after SCI. The expression of PSD95 and SYP of the 3D-C/S+ST group was significantly higher compared with SCI group (P < 0.01) and 3D-C/S group (P < 0.01), which suggested that implanting 3D-C/S+ST could facilitate the formation of synaptic connections at the injury site (Fig. 9A–C).
Discussion
Increasing studies demonstrated that the ST derived from MSCs can be an ideal substitute for MSCs transplantation. ST derived from HUCMSCs contains multiple proteins. Therefore, we hypothesized that the ST could have a good therapeutic potential on the treatment of SCI. In this study, we fabricated 3D printed collagen/silk fibroin scaffolds adsorbed with ST of HUCMSCs and implanted the scaffolds into the lesioned area of the rat spinal cord in the rats with complete spinal cord transection. The results showed that compared with 3D-C/S, 3D-C/S+ST could further promote neural regeneration and correspondently ameliorate locomotor function. The benefits of the ST for SCI repair were related to those 79 proteins.
The poor spontaneous regeneration ability after SCI is attributed to many complex biological processes. Microenvironment formed after SCI inhibits effective axon regeneration [67]. After complete spinal cord transection, the loss of all motor and sensory axonal tracts eliminates the possibility of lesion regeneration and recovery within a week, which is a huge challenge in current treatment [68]. The combination of biomaterials and neurotrophic factors can exert their respective advantages and provide excellent favorable effects.
Tissue engineering scaffolds should exhibit favorable biocompatibility, proper mechanical properties and good neuroinduction [69]. Collagen is widely used in the treatment of SCI thanks to its good cytocompatibility. Dai demonstrated that collagen scaffolds combined with neurotrophic factors could facilitate nerve regeneration after SCI in rats and Beagle dogs [70, 71]. However, the poor biomechanics and rapid degradation in vivo of collagen limit its use. Silk fibroin possesses some advantages, such as good biocompatibility, stable structure, high mechanical properties and slow degradation in vitro. Therefore, the combination of collagen and silk fibroin can greatly reduce each other’s shortcomings. An increasing number of studies indicated that MSCs and their ST can ameliorate the microenvironment of neurogenesis [72]. The growth factors of the ST have been shown to have a significant effect on neuron survival, differentiation and neurite growth [29, 38, 73]. The results of the cytokine antibody array demonstrated that ST derived from HUCMSCs contained 79 proteins among the 174 proteins analyzed. Treatment of CNS disease in the ST is related to multiple factors rather than a single factor. In our study, we fabricated porous 3D printed collagen/silk fibroin scaffold adsorbed with ST. The infrared spectroscopy data revealed that 3D-C/S+ST had suitable fat-soluble and water-soluble chemical bonds that were suitable for the adhesion and growth of nerve cells, hydrogen bonds between collagen/silk fibroin and ST may be formed. The results of DSC indicated that the interaction between ST and 3D printed collagen/silk fibroin might augmented the stability of ST. For X-ray diffraction analysis, 3D-C/S+ST owned ideal crystallinity, which facilitated the formation of the stability of the scaffold and the control of the degradation rate. After co-culturing with NSCs, the 3D-C/S+ST showed favorable cytocompatibility.
We established a rat T10 complete spinal cord transection model [74] and used BBB scores, inclined-grid climbing test, MEP, MRI and DTT to estimate neuroregeneration and function recovery. The results of behavioral assessment and electrophysiological studies could reveal the recovery of the 3D-C/S+ST group was significantly improved compared to SCI group and 3D-C/S group, suggesting that 3D-C/S+ST was conducive to the reconstruction of locomotor function after SCI. Locomotor function recovery was consistent with changes in imaging. MRI qualitatively describes the morphological changes of the tissue [75, 76], while DTI is a quantitative observation of the microstructure of the tissue. The combination of MRI and DTI in this study provides solid data to estimate repairing after SCI. FA values can reveal white matter integrity, such as damage to axon structures and demyelination. In our study, high FA values reflect favorable repair after SCI. DTT can track local fibers in the area of SCI and visualize the morphological changes of the spinal cord. Compared with traditional MRI, DTI is more sensitive to detect the repair of SCI. The results of MRI and DTI indicated the repair of SCI was markedly enhanced in the 3D-C/S+ST group compared to SCI group and 3D-C/S group. Histological analysis could provide more precise evidence for locomotor function repair. For the macroscopic histology images HE staining, we found implanting 3D-C/S+ST could markedly reduce cavity formation and facilitate spinal tissue regeneration. Bielschowsky’s silver staining revealed that implanting 3D-C/S+ST could further promote the regeneration of spinal nerve fibers compared to implanting 3D-C/S, indicating the ST derived from HUCMSCs created a favorable microenvironment for the repair of SCI. As a critical protein on the myelin sheath, MBP is a necessary structure for nerve impulses to conduct along axons. Immunofluorescence staining showed that the implantation of 3D-C/S+ST significantly increased NF-positive nerve fibers and NF-positive nerve fibers associated with myelin sheath at the injury/graft site, suggesting the implantation of 3D-C/S+ST could provide a suitable microenvironment to facilitate the regeneration of nerve fibers and myelin sheath. TEM analysis indicated transplantation of 3D-C/S+ST enhanced remyelination at the injury site. PSD95 is a post-synaptic marker and SYP is a presynaptic marker. The implantation of 3D-C/S+ST promoted the establishment of synaptic connections at the injury site, which is anatomically crucial for the recovery of neurological function.
However, our study has some limitations. Many functions of 3D-C/S+ST have not been explored in our study. Therefore, we need to investigate whether 3D-C/S+ST can promote cell differentiation, remove reactive oxygen species and reduce inflammation in the injured microenvironment in the future.
Conclusion
We demonstrated that 3D printed collagen/silk fibroin scaffolds carrying MSCs ST ameliorated neurological dysfunction by bridging spinal cord lesions to partially reconstruct neuronal circuits after SCI in rats, suggesting the implantation of 3D printed collagen/silk fibroin scaffolds carrying MSCs ST have the potential to become a novel and safer treatment for SCI repair.
Funding
This work was supported by the National Key Research and Development Plan of China (2021YFF1200800), the National Nature Scientific Fund of China (82171861, 81771352, 81971782, 81671222 and 81771350) and the Nature Scientific Fund of Tianjin (18JCJQJC48500 and 19JCYBJC27900).
Conflict of interest statement. There are no actual or potential conflicts of interest.
References
- 1. Wang Y, Wu M, Gu L, Li X, He J, Zhou L, Tong A, Shi J, Zhu H, Xu J, Guo G. Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles. Drug Deliv 2017;24:391–401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Chen X, Zhao Y, Li X, Xiao Z, Yao Y, Chu Y, Farkas B, Romano I, Brandi F, Dai J. Functional multichannel poly(propylene fumarate)-collagen scaffold with collagen-binding neurotrophic factor 3 promotes neural regeneration after transected spinal cord injury. Adv Healthc Mater 2018;7:e1800315. [DOI] [PubMed] [Google Scholar]
- 3. Rao JS, Zhao C, Zhang A, Duan H, Hao P, Wei RH, Shang J, Zhao W, Liu Z, Yu J, Fan KS, Tian Z, He Q, Song W, Yang Z, Sun YE, Li X. NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. Proc Natl Acad Sci USA 2018;115:E5595–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Li L, Xiao B, Mu J, Zhang Y, Zhang C, Cao H, Chen R, Patra HK, Yang B, Feng S, Tabata Y, Slater N, Tang J, Shen Y, Gao J. A MnO(2) Nanoparticle-dotted hydrogel promotes spinal cord repair via regulating reactive oxygen species microenvironment and synergizing with mesenchymal stem cells. ACS Nano 2019;13:14283–93. [DOI] [PubMed] [Google Scholar]
- 5. Li X, Liu D, Xiao Z, Zhao Y, Han S, Chen B, Dai J. Scaffold-facilitated locomotor improvement post complete spinal cord injury: motor axon regeneration versus endogenous neuronal relay formation. Biomaterials 2019;197:20–31. [DOI] [PubMed] [Google Scholar]
- 6. Li XL, Wu M, Gu L, Ren YT, Mu M, Wang YL, Gao X, Li JL, Tong AP, Zhu HY. A single dose of thermal-sensitive biodegradable hybrid hydrogel promotes functional recovery after spinal cord injury. Appl Mater Today 2019;14:66–75. [Google Scholar]
- 7. GrandPré T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439–44. [DOI] [PubMed] [Google Scholar]
- 8. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002;417:941–4. [DOI] [PubMed] [Google Scholar]
- 9. Lang BT, Cregg JM, DePaul MA, Tran AP, Xu K, Dyck SM, Madalena KM, Brown BP, Weng YL, Li S, Karimi-Abdolrezaee S, Busch SA, Shen Y, Silver J. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Nature 2015;518:404–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Yang Z, Zhang A, Duan H, Zhang S, Hao P, Ye K, Sun YE, Li X. NT3-chitosan elicits robust endogenous neurogenesis to enable functional recovery after spinal cord injury. Proc Natl Acad Sci USA 2015;112:13354–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Chen C, Zhao ML, Zhang RK, Lu G, Zhao CY, Fu F, Sun HT, Zhang S, Tu Y, Li XH. Collagen/heparin sulfate scaffolds fabricated by a 3D bioprinter improved mechanical properties and neurological function after spinal cord injury in rats. J Biomed Mater Res A 2017;105:1324–32. [DOI] [PubMed] [Google Scholar]
- 12. Zhang S, Wang XJ, Li WS, Xu XL, Hu JB, Kang XQ, Qi J, Ying XY, You J, Du YZ. Polycaprolactone/polysialic acid hybrid, multifunctional nanofiber scaffolds for treatment of spinal cord injury. Acta Biomater 2018;77:15–27. [DOI] [PubMed] [Google Scholar]
- 13. Hu Y, Zhang F, Zhong W, Liu Y, He Q, Yang M, Chen H, Xu X, Bian K, Xu J, Li J, Shen Y, Zhang H. Transplantation of neural scaffolds consisting of dermal fibroblast-reprogrammed neurons and 3D silk fibrous materials promotes the repair of spinal cord injury. J Mater Chem B 2019;7:7525–39. [DOI] [PubMed] [Google Scholar]
- 14. Shen H, Xu B, Yang C, Xue W, You Z, Wu X, Ma D, Shao D, Leong K, Dai J. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury. Biomaterials 2022;280:121279. [DOI] [PubMed] [Google Scholar]
- 15. Li G, Che MT, Zhang K, Qin LN, Zhang YT, Chen RQ, Rong LM, Liu S, Ding Y, Shen HY, Long SM, Wu JL, Ling EA, Zeng YS. Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury. Biomaterials 2016;83:233–48. [DOI] [PubMed] [Google Scholar]
- 16. Limongi T, Rocchi A, Cesca F, Tan H, Miele E, Giugni A, Orlando M, Perrone Donnorso M, Perozziello G, Benfenati F, Di Fabrizio E. Delivery of brain-derived neurotrophic factor by 3D biocompatible polymeric scaffolds for neural tissue engineering and neuronal regeneration. Mol Neurobiol 2018;55:8788–98. [DOI] [PubMed] [Google Scholar]
- 17. Xie Y, Song W, Zhao W, Gao Y, Shang J, Hao P, Yang Z, Duan H, Li X. Application of the sodium hyaluronate-CNTF scaffolds in repairing adult rat spinal cord injury and facilitating neural network formation. Sci China Life Sci 2018;61:559–68. [DOI] [PubMed] [Google Scholar]
- 18. Oudega M, Hao P, Shang J, Haggerty AE, Wang Z, Sun J, Liebl DJ, Shi Y, Cheng L, Duan H, Sun YE, Li X, Lemmon VP. Validation study of neurotrophin-3-releasing chitosan facilitation of neural tissue generation in the severely injured adult rat spinal cord. Exp Neurol 2019;312:51–62. [DOI] [PubMed] [Google Scholar]
- 19. Li G, Zhang B, Sun JH, Shi LY, Huang MY, Huang LJ, Lin ZJ, Lin QY, Lai BQ, Ma YH, Jiang B, Ding Y, Zhang HB, Li MX, Zhu P, Wang YQ, Zeng X, Zeng YS. An NT-3-releasing bioscaffold supports the formation of TrkC-modified neural stem cell-derived neural network tissue with efficacy in repairing spinal cord injury. Bioact Mater 2021;6:3766–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bajaj P, Schweller RM, Khademhosseini A, West JL, Bashir R. 3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng 2014;16:247–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Inzana JA, Olvera D, Fuller SM, Kelly JP, Graeve OA, Schwarz EM, Kates SL, Awad HA. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 2014;35:4026–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Sun Y, Yang C, Zhu X, Wang JJ, Liu XY, Yang XP, An XW, Liang J, Dong HJ, Jiang W, Chen C, Wang ZG, Sun HT, Tu Y, Zhang S, Chen F, Li XH. 3D printing collagen/chitosan scaffold ameliorated axon regeneration and neurological recovery after spinal cord injury. J Biomed Mater Res A 2019;107:1898–908. [DOI] [PubMed] [Google Scholar]
- 23. Bianco P, Robey PG, Simmons PJ.. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005;102:18171–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Keimpema E, Fokkens MR, Nagy Z, Agoston V, Luiten PG, Nyakas C, Boddeke HW, Copray JC. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol 2009;35:89–102. [DOI] [PubMed] [Google Scholar]
- 26. Wu GH, Shi HJ, Che MT, Huang MY, Wei QS, Feng B, Ma YH, Wang LJ, Jiang B, Wang YQ, Han I, Ling EA, Zeng X, Zeng YS. Recovery of paralyzed limb motor function in canine with complete spinal cord injury following implantation of MSC-derived neural network tissue. Biomaterials 2018;181:15–34. [DOI] [PubMed] [Google Scholar]
- 27. Estrada R, Li N, Sarojini H, An J, Lee MJ, Wang E. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 2009;219:563–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration. Cell Mol Life Sci 2013;70:3871–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Teixeira FG, Carvalho MM, Neves-Carvalho A, Panchalingam KM, Behie LA, Pinto L, Sousa N, Salgado AJ. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev Rep 2015;11:288–97. [DOI] [PubMed] [Google Scholar]
- 30. Zhao Y, Gibb SL, Zhao J, Moore AN, Hylin MJ, Menge T, Xue H, Baimukanova G, Potter D, Johnson EM, Holcomb JB, Cox CS, Dash PK, Pati S. Wnt3a, a protein secreted by mesenchymal stem cells is neuroprotective and promotes neurocognitive recovery following traumatic brain injury. Stem Cells 2016;34:1263–72. [DOI] [PubMed] [Google Scholar]
- 31. Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S, Manadas B, Behie LA, Sousa N, Salgado AJ. Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of Parkinson’s disease. Stem Cells Transl Med 2017;6:634–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012;10:244–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Drago D, Cossetti C, Iraci N, Gaude E, Musco G, Bachi A, Pluchino S. The stem cell secretome and its role in brain repair. Biochimie 2013;95:2271–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Tran C, Damaser MS.. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev 2015;82–83:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, Hensley MT, Dinh PU, Cores J, Li TS, Zhang J, Kan Q, Cheng K. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun 2017;8:13724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Silva WA, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003;21:661–9. [DOI] [PubMed] [Google Scholar]
- 37. Pires AO, Mendes-Pinheiro B, Teixeira FG, Anjo SI, Ribeiro-Samy S, Gomes ED, Serra SC, Silva NA, Manadas B, Sousa N. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis. Stem Cells Dev 2016;25:1073–83. [DOI] [PubMed] [Google Scholar]
- 38. Sart S, Liu Y, Ma T, Li Y. Microenvironment regulation of pluripotent stem cell-derived neural progenitor aggregates by human mesenchymal stem cell secretome. Tissue Eng Part A 2014;20: 2666–79. [DOI] [PubMed] [Google Scholar]
- 39. Yang Z, Duan H, Mo L, Qiao H, Li X. The effect of the dosage of NT-3/chitosan carriers on the proliferation and differentiation of neural stem cells. Biomaterials 2010;31:4846–54. [DOI] [PubMed] [Google Scholar]
- 40. Bauknight WM, Chakrabarty S, Hwang BY, Malone HR, Joshi S, Bruce JN, Sander Connolly E, Winfree CJ, Cunningham MG, Martin JH, Haque R. Convection enhanced drug delivery of BDNF through a microcannula in a rodent model to strengthen connectivity of a peripheral motor nerve bridge model to bypass spinal cord injury. J Clin Neurosci 2012;19:563–9. [DOI] [PubMed] [Google Scholar]
- 41. Haggerty AE, Oudega M.. Biomaterials for spinal cord repair. Neurosci Bull 2013;29:445–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Lai BQ, Che MT, Du BL, Zeng X, Ma YH, Feng B, Qiu XC, Zhang K, Liu S, Shen HY, Wu JL, Ling EA, Zeng YS. Transplantation of tissue engineering neural network and formation of neuronal relay into the transected rat spinal cord. Biomaterials 2016;109:40–54. [DOI] [PubMed] [Google Scholar]
- 43. Kubinová S, Syková E.. Biomaterials combined with cell therapy for treatment of spinal cord injury. Regen Med 2012;7:207–24. [DOI] [PubMed] [Google Scholar]
- 44. Wang J, Yang Q, Cheng N, Tao X, Zhang Z, Sun X, Zhang Q. Collagen/silk fibroin composite scaffold incorporated with PLGA microsphere for cartilage repair. Mater Sci Eng C Mater Biol Appl 2016;61:705–11. [DOI] [PubMed] [Google Scholar]
- 45. Schmidt T, Stachon S, Mack A, Rohde M, Just L. Evaluation of a thin and mechanically stable collagen cell carrier. Tissue Eng Part C Methods 2011;17:1161–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Chen X, Qi YY, Wang LL, Yin Z, Yin GL, Zou XH, Ouyang HW. Ligament regeneration using a knitted silk scaffold combined with collagen matrix. Biomaterials 2008;29:3683–92. [DOI] [PubMed] [Google Scholar]
- 47. Sun K, Li H, Li R, Nian Z, Li D, Xu C. Silk fibroin/collagen and silk fibroin/chitosan blended three-dimensional scaffolds for tissue engineering. Eur J Orthop Surg Traumatol 2015;25:243–9. [DOI] [PubMed] [Google Scholar]
- 48. Shrestha B, Coykendall K, Li Y, Moon A, Priyadarshani P, Yao L. Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res Ther 2014;5:91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Friedman JA, Windebank AJ, Moore MJ, Spinner RJ, Currier BL, Yaszemski MJ. Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery 2002;51:742–51; discussion 751–2. [PubMed] [Google Scholar]
- 50. Wong DY, Krebsbach PH, Hollister SJ.. Brain cortex regeneration affected by scaffold architectures. J Neurosurg 2008;109:715–22. [DOI] [PubMed] [Google Scholar]
- 51. Michalski MH, Ross JS.. The shape of things to come: 3D printing in medicine. JAMA 2014;312:2213–4. [DOI] [PubMed] [Google Scholar]
- 52. Schubert C, van Langeveld MC, Donoso LA.. Innovations in 3D printing: a 3D overview from optics to organs. Br J Ophthalmol 2014;98:159–61. [DOI] [PubMed] [Google Scholar]
- 53. Dong HJ, Zhao M, Li X, Chen Y, Wang J, Chen M, Wu S, Wang J, Liang H, Sun H. Hypothermia-modulating matrix elasticity of injured brain promoted neural lineage specification of mesenchymal stem cells. Neuroscience 2018;377:1–11. [DOI] [PubMed] [Google Scholar]
- 54. Tu Y, Chen C, Sun H, Cheng S, Liu X, Qu Y, Li X, Zhang S. Combination of temperature-sensitive stem cells and mild hypothermia: a new potential therapy for severe traumatic brain injury. J Neurotrauma 2012;29:2393–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Jiang J, Dai C, Liu X, Dai L, Li R, Ma K, Xu H, Zhao F, Zhang Z, He T, Niu X, Chen X, Zhang S. Implantation of regenerative complexes in traumatic brain injury canine models enhances the reconstruction of neural networks and motor function recovery. Theranostics 2021;11:768–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Liu XY, Wei MG, Liang J, Xu HH, Wang JJ, Wang J, Yang XP, Lv FF, Wang KQ, Duan JH, Tu Y, Zhang S, Chen Li XH. Injury-preconditioning secretome of umbilical cord mesenchymal stem cells amplified the neurogenesis and cognitive recovery after severe traumatic brain injury in rats. J Neurochem 2020;153:230–51. [DOI] [PubMed] [Google Scholar]
- 57. Ruan Y, Lin H, Yao J, Chen Z, Shao Z. Preparation of 3D fibroin/chitosan blend porous scaffold for tissue engineering via a simplified method. Macromol Biosci 2011;11:419–26. [DOI] [PubMed] [Google Scholar]
- 58. Xu Y, Zhang Z, Chen X, Li R, Li D, Feng S. A silk fibroin/collagen nerve scaffold seeded with a co-culture of Schwann cells and adipose-derived stem cells for sciatic nerve regeneration. PLoS One 2016;11:e0147184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Jiang JP, Liu XY, Zhao F, Zhu X, Li XY, Niu XG, Yao ZT, Dai C, Xu HY, Ma K, Chen XY, Zhang S. Three-dimensional bioprinting collagen/silk fibroin scaffold combined with neural stem cells promotes nerve regeneration after spinal cord injury. Neural Regen Res 2020;15:959–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Liu XY, Liang J, Wang Y, Zhong L, Zhao CY, Wei MG, Wang JJ, Sun XZ, Wang KQ, Duan JH, Chen C, Tu Y, Zhang S, Ming D, Li XH. Diffusion tensor imaging predicting neurological repair of spinal cord injury with transplanting collagen/chitosan scaffold binding bFGF. J Mater Sci Mater Med 2019;30:123. [DOI] [PubMed] [Google Scholar]
- 61. Harris J, Lee H, Tu CT. Preparing E18 cortical rat neurons for compartmentalization in a microfluidic device. J Vis Exp 2007;8:305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Ma Z, Zhang YP, Liu W, Yan G, Li Y, Shields L, Walker M, Chen K. Huang W, Kong M, Lu Y, Brommer B, Chen X, Xu XM, Shields CB. A controlled spinal cord contusion for the rhesus macaque monkey. Exp Neurol 2016;279:261–73. [DOI] [PubMed] [Google Scholar]
- 63. Zeng X, Zeng YS, Ma YH, Lu LY, Du BL, Zhang W, Li Y, Chan WY. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury. Cell Transplant 2011;20:1881–99. [DOI] [PubMed] [Google Scholar]
- 64. Xu X, Li N, Zhu L, Zhou Y, Cheng H. Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats. J Spinal Cord Med 2016;39:220–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Cai Z, Gan Y, Bao C, Wu W, Wang X, Zhang Z, Zhou Q, Lin Q, Yang Y, Zhu L. Photosensitive hydrogel creates favorable biologic niches to promote spinal cord injury repair. Adv Healthc Mater 2019;8:e1900013. [DOI] [PubMed] [Google Scholar]
- 66. Yao S, Yu S, Cao Z, Yang Y, Yu X, Mao HQ, Wang LN, Sun X, Zhao L, Wang X. Hierarchically aligned fibrin nanofiber hydrogel accelerated axonal regrowth and locomotor function recovery in rat spinal cord injury. Int J Nanomedicine 2018;13:2883–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci 2017;20:637–47. [DOI] [PubMed] [Google Scholar]
- 68. Siebert JR, Eade AM, Osterhout DJ.. Biomaterial approaches to enhancing neurorestoration after spinal cord injury: strategies for overcoming inherent biological obstacles. BioMed Res Int 2015;2015:752572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Kaneko A, Matsushita A, Sankai Y.. A 3D nanofibrous hydrogel and collagen sponge scaffold promotes locomotor functional recovery, spinal repair, and neuronal regeneration after complete transection of the spinal cord in adult rats. Biomed Mater 2015;10:015008. [DOI] [PubMed] [Google Scholar]
- 70. Han Q, Jin W, Xiao Z, Ni H, Wang J, Kong J, Wu J, Liang W, Chen L, Zhao Y, Chen B, Dai J. The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody. Biomaterials 2010;31:9212–20. [DOI] [PubMed] [Google Scholar]
- 71. Han S, Wang B, Jin W, Xiao Z, Li X, Ding W, Kapur M, Chen B, Yuan B, Zhu T, Wang H, Wang J, Dong Q, Liang W, Dai J. The linear-ordered collagen scaffold-BDNF complex significantly promotes functional recovery after completely transected spinal cord injury in canine. Biomaterials 2015;41:89–96. [DOI] [PubMed] [Google Scholar]
- 72. Salgado AJ, Sousa JC, Costa BM, Pires AO, Mateus-Pinheiro A, Teixeira FG, Pinto L, Sousa N. Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities. Front Cell Neurosci 2015;9:249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Kim DH, Lee D, Chang EH, Kim JH, Hwang JW, Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, Na DL, Oh W, Chang JW. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer’s disease model. Stem Cells Dev 2015;24:2378–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES, Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2012;150:1264–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Huang SL, He XJ, Xiang L, Yuan GL, Ning N, Lan BS. CT and MRI features of patients with diastematomyelia. Spinal Cord 2014;52:689–92. [DOI] [PubMed] [Google Scholar]
- 76. Huang SL, Liu YX, Yuan GL, Zhang J, Yan HW. Characteristics of lumbar disc herniation with exacerbation of presentation due to spinal manipulative therapy. Medicine (Baltimore) 2015;94:e661. [DOI] [PMC free article] [PubMed] [Google Scholar]